2026 NPPES data Transplant Hepatology Physician NPI 1780604645 M.D.
Verify on CMS →

STEWART COOPER, M.D.

Transplant Hepatology Physician in SAN FRANCISCO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
756
Medicare Part D claims · 76 beneficiaries · Transplant Hepatology Physician avg: 536
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

STEWART COOPER, M.D. filed 756 Medicare Part D claims in 2023 as a Transplant Hepatology Physician in SAN FRANCISCO, California, prescribing 56% generic.

756
Part D claims, 2023
56%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEWART COOPER, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

756 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

STEWART COOPER, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEWART COOPER, M.D.?

Quality data not reported

NPI registry status

Active

Issued 07/20/2006

NPI 1780604645

Primary specialty

Transplant Hepatology Physician

Rare

131 US NPIs in this specialty

Medicare Part D claims

756 41% vs specialty avg

2023 prescription claims

Specialty avg: 536

Specialty distribution in California

How Transplant Hepatology Physician compares to other specialties among California providers

California providers

Transplant Hepatology Physician share within California

1. Transplant Hepatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Transplant Hepatology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Transplant Hepatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Transplant Hepatology Physician ABMS/AOA estimate

Est. board-certified rate (Transplant Hepatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Transplant Hepatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEWART COOPER, M.D. appears in the CMS NPPES registry as a Transplant Hepatology Physician provider holding M.D. credentials at 1100 VAN NESS AVE, SAN FRANCISCO, CA, 94109, with a listed phone of (415) 600-1000. NPI 1780604645 was issued on 07/20/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what COOPER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 756 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $781K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Transplant Hepatology Physician is a narrow specialty nationwide, with 131 enrolled providers across 36 states and an average of 536 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1100 VAN NESS AVE
SAN FRANCISCO, CA 94109

Provider Details

NPI 1780604645
Specialty Transplant Hepatology Physician
Credentials M.D.
Gender Male
NPI Issued 07/20/2006

Hospital and facility affiliations

Facilities where STEWART COOPER, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SUTTER BAY MEDICAL FOUNDATION
SAN FRANCISCO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to STEWART COOPER, M.D.. To verify STEWART COOPER, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

STEWART COOPER, M.D. — brand share 44.0%
Specialty average (est.)

44% brand-name claims vs 56% generic, on 756 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

756
Total Claims
$781K
Total Drug Cost
76
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,214
Total Day Supply
35,985
Brand vs Generic
44% brand / 56% generic
Brand Drug Cost
$581K
Generic Drug Cost
$200K
Antibiotic Claims
54

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
2.03
Gender Split
50% female / 50% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEWART COOPER, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Vemlidy
Tenofovir Alafenamide
284
Entecavir
107
Tacrolimus
58
Xifaxan
Rifaximin
34
Pantoprazole Sodium
26
Ursodiol
26
Furosemide
22
Eplerenone
21
Prednisone
20
Ciprofloxacin Hcl
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Transplant Hepatology Physician Overview

How STEWART COOPER, M.D. fits within the Transplant Hepatology Physician landscape nationally.

131
Transplant Hepatology Physician Providers in US
36
States with Transplant Hepatology Physician
536
Avg Claims per Provider

STEWART COOPER, M.D.'s 756 claims are above the specialty average of 536.

Nearby Transplant Hepatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as COOPER.

Compare Transplant Hepatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEWART COOPER, M.D.'s specialty?
STEWART COOPER, M.D. specializes in Transplant Hepatology Physician and practices in SAN FRANCISCO, California. Credentials: M.D..
How much does STEWART COOPER, M.D. prescribe under Medicare Part D?
In 2023, STEWART COOPER, M.D. wrote 756 Medicare Part D claims totaling $781K in drug costs for 76 beneficiaries.
Where is STEWART COOPER, M.D. located?
STEWART COOPER, M.D. is located at 1100 VAN NESS AVE, SAN FRANCISCO, CA, 94109. Phone: (415) 600-1000.
What is STEWART COOPER, M.D.'s NPI number?
STEWART COOPER, M.D.'s National Provider Identifier (NPI) is 1780604645, issued on 07/20/2006.
Does STEWART COOPER, M.D. prescribe more brand-name or generic drugs?
STEWART COOPER, M.D.'s prescribing is 44% brand-name and 56% generic drugs by claim count, with $581K in brand drug costs.
How many Transplant Hepatology Physician providers are there in the US?
There are 131 Transplant Hepatology Physician providers across 36 states in the US. The average Transplant Hepatology Physician provider writes 536 Medicare Part D claims per year.
What drugs does STEWART COOPER, M.D. prescribe most often?
Based on 2023 Medicare Part D data, STEWART COOPER, M.D.'s most frequently prescribed drugs include Vemlidy, Entecavir, Tacrolimus. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEWART COOPER, M.D. accept Medicare?
STEWART COOPER, M.D. appears in CMS Medicare data with 756 Part D claims and 76 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEWART COOPER, M.D.'s credentials?
STEWART COOPER, M.D.'s NPI is 1780604645 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology